NasdaqCM - Delayed Quote USD
Purple Biotech Ltd (PPBT)
2.2050
-0.0150
(-0.68%)
At close: May 9 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-14,367
-14,367
-19,925
-16,735
-15,251
Investing Cash Flow
509
509
13,881
19,914
13,406
Financing Cash Flow
6,774
6,774
5,449
1,114
1,512
Cash Flow from Discontinued Operation
--
--
--
--
-374
End Cash Position
7,401
7,401
14,489
15,030
10,890
Capital Expenditure
--
--
-3
-228
-115
Issuance of Capital Stock
5,809
5,809
1,563
1,498
564
Repayment of Debt
-183
-183
-168
-165
-153
Free Cash Flow
-14,367
-14,367
-19,928
-16,963
-15,366
12/31/2021 - 11/20/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVGN Evogene Ltd.
1.1325
+0.22%
CANF Can-Fite BioPharma Ltd.
1.1100
-0.45%
CYCN Cyclerion Therapeutics, Inc.
3.2784
+4.74%
BCLI Brainstorm Cell Therapeutics Inc.
1.1800
-3.28%
SNTI Senti Biosciences, Inc.
3.2600
-1.51%
XTLB XTL Biopharmaceuticals Ltd.
1.2600
+1.61%
FBRX Forte Biosciences, Inc.
6.38
+2.41%
ENLV Enlivex Therapeutics Ltd.
1.0200
-2.86%
CGEN Compugen Ltd.
1.2600
-2.33%
OSRH OSR Holdings, Inc.
1.2500
-2.34%